Tuesday, July 23, 2019

University of Aberdeen create drug discovery venture to tackle disease

New treatments for some of the most common diseases and conditions could be on the horizon with the launch of a new drug discovery...

GPhC launch helpline to clarify next month’s regulatory changes

The General Pharmaceutical Council has today announced the launch of a new GPhC telephone helpline to help registrants understand the change in regulation which...

ImmunoSolv completes merger with Aberdeen-based Grampian BioConsultants Limited

ImmunoSolv a leading Edinburgh-based private company developer of immunology platform technology has completed a merger with Aberdeen-based Grampian BioConsultants Limited. The merger which will see...

Co-operative Pharmacy reports operating profits of ?18 million

The Co-operative Pharmacy has reported operating profits of £18 million for the first half of 2010 representing a rise of 26%. The rise was attributed...

NICE advice for pregnant women at risk of pre-eclampsia

The National Institute for health and Clinical Excellence has recommended that pregnant women at high risk of pre-eclampsia should take aspirin 75mg daily from...

South coast pharmacies defy cuts to promote stop smoking schemes

South coast pharmacies are defying enhanced service cuts to see their stop smoking schemes thrive. Pharmacists in Dorset were responsible for more than a third...

RPSGB rule in favour of exam fixing pharmacy tutor

The Royal Pharmaceutical Society of Great Britain disciplinary committee has ruled that a pharmacy tutor who fixed exam papers to ensure students passed can...

PDA attacks Boots’ advance declaration procedure

The Pharmacists’ Defence Association has attacked an "advance declaration" procedure that Boots has developed to allow its pharmacies to operate without a pharmacist present. The...

Novartis receives U.S endorsement for high blood pressure treatment

Swiss drug maker Novartis AG has received U.S approval for a new high blood pressure treatment by broadening the use of Tekturna the successor...